35571246|t|Thioredoxin-Interacting Protein (TXNIP) Knockdown Protects against Sepsis-Induced Brain Injury and Cognitive Decline in Mice by Suppressing Oxidative Stress and Neuroinflammation.
35571246|a|Sepsis-associated encephalopathy (SAE) is linked to increased morbidity and mortality rates in patients with sepsis. Increased cytokine production and neuronal apoptosis are implicated in the pathogenesis of the SAE. Neuroinflammation plays a major role in sepsis-induced brain injury. Thioredoxin-interacting protein (TXNIP), an inhibitor of thioredoxin, is associated with oxidative stress and inflammation. However, whether the TXNIP is involved in the sepsis-induced brain injury and the underlying mechanism is yet to be elucidated. Therefore, the present study was aimed at elucidating the effects of TXNIP knockdown on sepsis-induced brain injury and cognitive decline in mice. Lipopolysaccharide (LPS) was injected intraperitoneally to induce sepsis brain injury in mice. The virus-carrying control or TXNIP shRNA was injected into the lateral ventricle of the brain 4 weeks before the LPS treatment. The histological changes in the hippocampal tissues, encephaledema, and cognitive function were detected, respectively. Also, the 7-day survival rate was recorded. Furthermore, the alterations in microglial activity, oxidative response, proinflammatory factors, apoptosis, protein levels (TXNIP and NLRP3 inflammasome), and apoptosis were examined in the hippocampal tissues. The results demonstrated that the TXNIP and NLRP3 inflammasome expression levels were increased at 6, 12, and 24 h post-LPS injection. TXNIP knockdown dramatically ameliorated the 7-day survival rate, cognitive decline, brain damage, neuronal apoptosis, and the brain water content, inhibited the activation of microglia, downregulated the NLRP3/caspase-1 signaling pathway, and reduced the oxidative stress and the neuroinflammatory cytokine levels at 24 h post-LPS injection. These results suggested a crucial effect of TXNIP knockdown on the mechanism of brain injury and cognitive decline in sepsis mice via suppressing oxidative stress and neuroinflammation. Thus, TXNIP might be a potential therapeutic target for SAE patients.
35571246	0	31	Thioredoxin-Interacting Protein	Gene	56338
35571246	33	38	TXNIP	Gene	56338
35571246	67	73	Sepsis	Disease	MESH:D018805
35571246	82	94	Brain Injury	Disease	MESH:D001930
35571246	99	116	Cognitive Decline	Disease	MESH:D003072
35571246	120	124	Mice	Species	10090
35571246	161	178	Neuroinflammation	Disease	MESH:D000090862
35571246	180	212	Sepsis-associated encephalopathy	Disease	MESH:D065166
35571246	214	217	SAE	Disease	MESH:D065166
35571246	275	283	patients	Species	9606
35571246	289	295	sepsis	Disease	MESH:D018805
35571246	331	349	neuronal apoptosis	Disease	MESH:D065703
35571246	392	395	SAE	Disease	MESH:D065166
35571246	397	414	Neuroinflammation	Disease	MESH:D000090862
35571246	437	443	sepsis	Disease	MESH:D018805
35571246	452	464	brain injury	Disease	MESH:D001930
35571246	466	497	Thioredoxin-interacting protein	Gene	56338
35571246	499	504	TXNIP	Gene	56338
35571246	523	534	thioredoxin	Gene	22166
35571246	576	588	inflammation	Disease	MESH:D007249
35571246	611	616	TXNIP	Gene	56338
35571246	636	642	sepsis	Disease	MESH:D018805
35571246	651	663	brain injury	Disease	MESH:D001930
35571246	787	792	TXNIP	Gene	56338
35571246	806	812	sepsis	Disease	MESH:D018805
35571246	821	833	brain injury	Disease	MESH:D001930
35571246	838	855	cognitive decline	Disease	MESH:D003072
35571246	859	863	mice	Species	10090
35571246	865	883	Lipopolysaccharide	Chemical	MESH:D008070
35571246	885	888	LPS	Chemical	MESH:D008070
35571246	931	950	sepsis brain injury	Disease	MESH:D001930
35571246	954	958	mice	Species	10090
35571246	990	995	TXNIP	Gene	56338
35571246	1074	1077	LPS	Chemical	MESH:D008070
35571246	1142	1155	encephaledema	Disease	
35571246	1326	1341	proinflammatory	Disease	
35571246	1378	1383	TXNIP	Gene	56338
35571246	1388	1393	NLRP3	Gene	216799
35571246	1499	1504	TXNIP	Gene	56338
35571246	1509	1514	NLRP3	Gene	216799
35571246	1585	1588	LPS	Chemical	MESH:D008070
35571246	1600	1605	TXNIP	Gene	56338
35571246	1666	1683	cognitive decline	Disease	MESH:D003072
35571246	1685	1697	brain damage	Disease	MESH:D001925
35571246	1699	1717	neuronal apoptosis	Disease	MESH:D065703
35571246	1805	1810	NLRP3	Gene	216799
35571246	1811	1820	caspase-1	Gene	12362
35571246	1881	1898	neuroinflammatory	Disease	MESH:D000090862
35571246	1928	1931	LPS	Chemical	MESH:D008070
35571246	1987	1992	TXNIP	Gene	56338
35571246	2023	2035	brain injury	Disease	MESH:D001930
35571246	2040	2057	cognitive decline	Disease	MESH:D003072
35571246	2061	2067	sepsis	Disease	MESH:D018805
35571246	2068	2072	mice	Species	10090
35571246	2110	2127	neuroinflammation	Disease	MESH:D000090862
35571246	2135	2140	TXNIP	Gene	56338
35571246	2185	2188	SAE	Disease	MESH:D065166
35571246	2189	2197	patients	Species	9606
35571246	Positive_Correlation	MESH:D008070	56338
35571246	Association	MESH:D003072	56338
35571246	Association	MESH:D001925	56338
35571246	Association	MESH:D000090862	56338
35571246	Association	MESH:D001930	56338
35571246	Association	MESH:D018805	56338
35571246	Negative_Correlation	22166	56338
35571246	Association	MESH:D065703	56338
35571246	Positive_Correlation	MESH:D008070	MESH:D001930
35571246	Positive_Correlation	216799	56338
35571246	Association	MESH:D007249	56338
35571246	Positive_Correlation	MESH:D008070	216799
35571246	Positive_Correlation	12362	56338

